Aileron Therapeutics, Inc.

NasdaqCM:ALRN Stock Report

Market Cap: US$28.7m

Aileron Therapeutics Balance Sheet Health

Financial Health criteria checks 6/6

Aileron Therapeutics has a total shareholder equity of $11.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $12.8M and $1.6M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$12.07m
EquityUS$11.20m
Total liabilitiesUS$1.62m
Total assetsUS$12.82m

Recent financial health updates

Companies Like Aileron Therapeutics (NASDAQ:ALRN) Could Be Quite Risky

Aug 18
Companies Like Aileron Therapeutics (NASDAQ:ALRN) Could Be Quite Risky

Is Aileron Therapeutics (NASDAQ:ALRN) In A Good Position To Deliver On Growth Plans?

Dec 30
Is Aileron Therapeutics (NASDAQ:ALRN) In A Good Position To Deliver On Growth Plans?

Recent updates

Companies Like Aileron Therapeutics (NASDAQ:ALRN) Could Be Quite Risky

Aug 18
Companies Like Aileron Therapeutics (NASDAQ:ALRN) Could Be Quite Risky

Is Aileron Therapeutics (NASDAQ:ALRN) In A Good Position To Deliver On Growth Plans?

Dec 30
Is Aileron Therapeutics (NASDAQ:ALRN) In A Good Position To Deliver On Growth Plans?

Aileron Therapeutics: An Assessment On A Lottery Ticket

Oct 21

Aileron Therapeutics: Solving Chemotherapy's Toxicity

May 01

Aileron Therapeutics +31% on insider buying more shares

Jan 08

Aileron raises $40M via equity offering

Jan 06

Aileron Therapeutics EPS in-line

Nov 13

Financial Position Analysis

Short Term Liabilities: ALRN's short term assets ($12.8M) exceed its short term liabilities ($1.6M).

Long Term Liabilities: ALRN has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: ALRN is debt free.

Reducing Debt: ALRN had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ALRN has sufficient cash runway for 10 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: ALRN is forecast to have sufficient cash runway for 9 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.